Note 13 Stock-Based Compensation

9 Months Ended

Jun. 29, 2019

Share-based Payment Arrangement, Noncash Expense [Abstract]

Share-based Payment Arrangement [Text Block]

Stock-Based Compensation

Stock-based compensation expense was attributable to:

	Three Months Ended				Nine Months Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
	(In thousands)
Stock options	$	602	$	1,362	$	701	$	5,105
Restricted stock units, including performance based awards	7,534		8,399		19,877		23,593
Total	$	8,136	$	9,761	$	20,578	$	28,698

Stock-based compensation expense was recognized as follows:

	Three Months Ended				Nine Months Ended
	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
	(In thousands)
Cost of sales	$	2,729	$	2,055	$	7,046	$	6,354
Selling, general and administrative	5,328		7,490		13,257		22,042
Research and development	79		216		275		302
Total	$	8,136	$	9,761	$	20,578	$	28,698

The Company's 2009 Stock Plan ("2009 Plan") expired as to future grants on January 26, 2019. Although the 2009 Plan was terminated, it will continue to govern all awards granted under it prior to its termination date. On March 11, 2019, the Company's stockholders approved the Company's 2019 Equity Incentive Plan ("2019 Plan") and the reservation of 4.0 million shares of common stock for issuance thereunder, plus any shares subject to stock options or similar awards granted under the 2009 Plan that expire or otherwise terminate without having been exercised in full and shares issued pursuant to awards granted that are forfeited to or repurchased by the Company.

As of June 29, 2019, an aggregate of 9.6 million shares were authorized for future issuance under the Company's stock plans, of which 5.1 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 4.5 million shares of common stock were available for future grant.

Restricted Stock Units

Activity with respect to the Company's restricted stock units was as follows:

	Number of Shares		Weighted- Average Grant Date Fair Value ($)	Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value ($)
	(In thousands)				(In thousands)
Outstanding as of September 29, 2018	3,303		30.33	1.21	97,913
Granted	1,742		24.83
Vested/Forfeited/Cancelled	(1,977	)	29.46
Outstanding as of June 29, 2019	3,068		27.77	1.52	86,047
Expected to vest as of June 29, 2019	2,407		27.94	1.34	67,512

As of June 29, 2019, unrecognized compensation expense of $37 million is expected to be recognized over a weighted average period of 1.4 years. Additionally, as of June 29, 2019, unrecognized compensation expense related to performance-based restricted stock units for which achievement of the performance criteria is not currently considered probable was $11 million.